Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000204949 | SCV000260871 | pathogenic | Charcot-Marie-Tooth disease type 4A | 2022-12-12 | criteria provided, single submitter | clinical testing | Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. This sequence change affects a donor splice site in intron 4 of the GDAP1 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in GDAP1 are known to be pathogenic (PMID: 11743580). This variant is present in population databases (no rsID available, gnomAD 0.0009%). Disruption of this splice site has been observed in individuals with autosomal recessive Charcot-Marie-Tooth disease type 4A (PMID: 12566285). ClinVar contains an entry for this variant (Variation ID: 220379). For these reasons, this variant has been classified as Pathogenic. |
Molecular Genetics Laboratory, |
RCV000789161 | SCV001336397 | pathogenic | Charcot-Marie-Tooth disease | criteria provided, single submitter | clinical testing | ||
MGZ Medical Genetics Center | RCV002288831 | SCV002578966 | pathogenic | Charcot-Marie-Tooth disease axonal type 2K | 2022-03-22 | criteria provided, single submitter | clinical testing | |
OMIM | RCV001839450 | SCV000024590 | pathogenic | Charcot-Marie-Tooth disease recessive intermediate A | 2003-03-01 | no assertion criteria provided | literature only | |
Inherited Neuropathy Consortium | RCV000789161 | SCV000928513 | uncertain significance | Charcot-Marie-Tooth disease | no assertion criteria provided | literature only | ||
Clinical Genetics, |
RCV001795333 | SCV002034705 | pathogenic | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001795333 | SCV002035296 | pathogenic | not provided | no assertion criteria provided | clinical testing | ||
Inherited Neuropathy Consortium Ii, |
RCV002288831 | SCV004174649 | uncertain significance | Charcot-Marie-Tooth disease axonal type 2K | 2016-01-06 | no assertion criteria provided | literature only |